Integration of cytogenomic data for furthering the characterization of pediatric B-ALL: a multi-institution, multi-platform microarray study

Autor: Baughn, LB, Biegel, JA, South, ST, Smolarek, T, Volkert, S, Carroll, A, Heerema, NA, Rabin, KR, Zweidler-McKay, PA, Loh, M, Hirsch, B

It is well documented that among subgroups of B-cell acute lymphoblastic leukemia (B-ALL), the genetic profile of the leukemic blasts has significant impact on prognosis and stratification for therapy. Recent studies have documented the power of micr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::511c16d655f291cf1d6741ada955b594
https://europepmc.org/articles/PMC5361577/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).

Autor: Tang H; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Yan H; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Shivaram S; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Lehman S; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Sharma N; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Smadbeck J; Center for Individualized Medicine-Biomarker Discovery, Mayo Clinic, Rochester, MN, USA., Zepeda-Mendoza C; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Tian S; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Asmann Y; Division of Computational Biology, Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL, USA., Vachon C; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Gaspar Maia A; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Keats J; Integrated Cancer Genomics, Translational Genomics Research Institute (TGen), Phoenix, AZ, USA., Bergsagel PL; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA., Fonseca R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA., Stewart AK; Princess Margaret Cancer Centre, Toronto, ON, Canada., Hsu JS; Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA., Kandasamy RK; Division of Computational Biology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA., Pandey A; Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.; Manipal Academy of Higher Education, Manipal, Karnataka, India., Kaddoura MA; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Maura F; Division of Myeloma, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Mitra A; Drug Discovery and Development, Auburn University, Auburn, AL, USA., Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Kumar SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Elhaik E; Department of Biology, Lund University, Lund, Sweden., Braggio E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA., Baughn LB; Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. baughn.linda@mayo.edu.

Publikováno v: Leukemia [Leukemia] 2024 Oct 14. Date of Electronic Publication: 2024 Oct 14.

Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple Myeloma.

Autor: Maura F, Kaddoura M, Poos AM, Baughn LB, Ziccheddu B, Bärtsch MA, Cirrincione A, Maclachlan K, Chojnacka M, Diamond B, Papadimitriou M, Blaney P, John L, Reichert P, Huhn S, Gagler D, Zhang Y, Dogan A, Lesokhin AM, Davies F, Goldschmidt H, Fenk R, Weisel KC, Mai EK, Korde N, Morgan GJ, Rajkumar SV, Kumar S, Usmani S, Landgren O, Raab MS, Weinhold N

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.

Correction: Family history of plasma cell disorders is associated with improved survival in MGUS, multiple myeloma, and systemic AL amyloidosis.

Autor: Visram A; Division of Hematology, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Vachon C; Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Baughn LB; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, USA.; Division of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Larson D; Division of Biostatistics, Mayo Clinic, Rochester, MN, USA., Smadbeck J; Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, USA., Dispenzieri A; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Buadi FK; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Hayman SR; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Dingli D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kourelis T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Gonsalves W; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Warsame R; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Muchtar E; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Leung N; Division of Nephrology, Mayo Clinic, Rochester, MN, USA., Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kumar S; Division of Hematology, Mayo Clinic, Rochester, MN, USA. kumar.shaji@mayo.edu.

Publikováno v: Leukemia [Leukemia] 2024 Aug; Vol. 38 (8), pp. 1865.